Bharat Book

Depression - Pipeline Review, H2

Press Release   •   Dec 04, 2013 10:01 IST

Dec 04, 2013 : Bharat Book Bureau presents the new report, on 'Depression - Pipeline Review, H2 2013'  provides an overview of the indication’s therapeutic pipeline.It also reviews key players involved in the therapeutic development for Depression. Depression - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Depression.
- A review of the Depression products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Depression pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Depression.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Depression pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Mentioned

Bristol-Myers Squibb Company
Johnson & Johnson
Boehringer Ingelheim GmbH
AstraZeneca PLC
GlaxoSmithKline plc
Daiichi Sankyo Company, Ltd
Taisho Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Company Limited
Neurocrine Biosciences, Inc.
Aphios Corporation
Eisai Co., Ltd.
H Lundbeck A/S
Mitsubishi Tanabe Pharma Corporation
Pfizer Inc.
Sigma-Tau S.p.A.
Addex Pharmaceuticals
FAES Farma SA
Anavex Life Sciences Corp.
Karo Bio
KunWha Pharmaceutical Co., Ltd.
Newron Pharmaceuticals S.p.A.
M et P Pharma AG
Angelini Group
Domain Therapeutics
Ironwood Pharmaceuticals, Inc.
Abiogen Pharma S.p.A.
Ache Laboratorios Farmaceuticos S/A
Affectis Pharmaceuticals AG
Trevena, Inc.
Supernus Pharmaceuticals, Inc.
Psylin Neurosciences, Inc.
PsychoGenics, Inc.
Indus Biotech Private Limited
NeuroNascent, Inc.
Azevan Pharmaceuticals, Inc.
Concert Pharmaceuticals, Inc.
Dart NeuroScience LLC
Targacept, Inc.
AB Science
MAPREG
BrainCells Inc.
Heptares Therapeutics Ltd.
Pherin Pharmaceuticals, Inc.
Clera Inc.
Beech Tree Labs, Inc.
Reviva Pharmaceuticals Inc.

 

Table of contents :

Table of Contents 2
List of Tables 6
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Depression Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Depression 11
Depression Therapeutics under Development by Companies 13
Depression Therapeutics under Investigation by Universities/Institutes 18
Late Stage Products 20
Comparative Analysis 20
Mid Clinical Stage Products 21
Comparative Analysis 21
Early Clinical Stage Products 22
Comparative Analysis 22
Discovery and Pre-Clinical Stage Products 23
Comparative Analysis 23
Depression Therapeutics - Products under Development by Companies 24
Depression Therapeutics - Products under Investigation by Universities/Institutes 29
Companies Involved in Depression Therapeutics Development 31
Bristol-Myers Squibb Company 31
Johnson & Johnson 32
Boehringer Ingelheim GmbH 33
AstraZeneca PLC 34
GlaxoSmithKline plc 35
Daiichi Sankyo Company, Ltd 36
Taisho Pharmaceutical Co., Ltd. 37
Takeda Pharmaceutical Company Limited 38
Neurocrine Biosciences, Inc. 39
Aphios Corporation 40
Eisai Co., Ltd. 41
H Lundbeck A/S 42
Mitsubishi Tanabe Pharma Corporation 43
Pfizer Inc. 44
Sigma-Tau S.p.A. 45
Addex Pharmaceuticals 46
FAES Farma SA 47
Anavex Life Sciences Corp. 48
Karo Bio 49
KunWha Pharmaceutical Co., Ltd. 50
Newron Pharmaceuticals S.p.A. 51
M et P Pharma AG 52
Angelini Group 53
Domain Therapeutics 54
Ironwood Pharmaceuticals, Inc. 55
Abiogen Pharma S.p.A. 56
Ache Laboratorios Farmaceuticos S/A 57
Affectis Pharmaceuticals AG 58
Trevena, Inc. 59
Supernus Pharmaceuticals, Inc. 60
Psylin Neurosciences, Inc. 61
PsychoGenics, Inc. 62
Indus Biotech Private Limited 63
NeuroNascent, Inc. 64
Azevan Pharmaceuticals, Inc. 65
Concert Pharmaceuticals, Inc. 66
Dart NeuroScience LLC 67
Targacept, Inc. 68
AB Science 69
MAPREG 70
BrainCells Inc. 71
Heptares Therapeutics Ltd. 72
Pherin Pharmaceuticals, Inc. 73

For more information kindly visit : http://www.bharatbook.com/Healthcare-market-research-reports/Depression-Pipeline-Review-H2-20131.html

Related link : http://www.bharatbook.com/market-research-report/pharmaceuticals-and-healthcare.html

 

About Bharat Book Bureau:

Bharat Book Bureau is the leading market research information provider for market research reports, , company profiles, industry analysis , country reports , business reports, newsletters and online databases Bharat Book Bureau provides over a million reports from more than 400 publishers around the globe. We cover sectors starting from Aeronautics to Zoology.

In case the reports don't match your requirement then we can do a specialized Custom Research for you. Our multifarious capabilities, cross-sector expertise and detailed knowledge of various markets, put us in a unique position to take up Custom Research demands of yourself.

Contact us at :

Bharat Book Bureau
Tel: +91 22 27810772 / 27810773
Toll Free No for USA/Canada : 1-866-279-8368
Email: info@bharatbook.com 
Website: www.bharatbook.com 
Follow us on twitter: https://twitter.com/researchbook 
Follow us on linked in : http://www.linkedin.com/company/bharat-book-bureau 
Our Blog : http://blog.bharatbook.com/ 


Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.